Respiratory viral infections represent the leading cause of hospitalization in infants and
young children worldwide and the second leading cause of infant mortality. Among these …

MDA5 is a cytosolic sensor of double-stranded RNA (ds) RNA including viral byproducts and
intermediates. We studied a child with life-threatening, recurrent respiratory tract infections …

A high prevalence rate of macrolide-resistant Mycoplasma pneumoniae (MRMP) has been
reported in Asia. We performed a systematic review and meta-analysis to investigate the …

BACKGROUND: Substantial morbidity and excessive care variation are seen with pediatric
pneumonia. Accurate risk-stratification tools to guide clinical decision-making are needed …

Background Lower procalcitonin (PCT) concentrations are associated with reduced risk of
bacterial community-acquired pneumonia (CAP) in adults, but data in children are limited …

Although previous studies have reported the use of metabolomics for infectious diseases,
little is known about the potential function of plasma metabolites in children infected with …

The addition of pneumococcal conjugate vaccines (PCVs) to the United States (US) national
immunization program led to significant reductions in incidence, mortality, and associated …

BACKGROUND AND OBJECTIVES Current routine immunizations for children aged≤ 10
years in the United States in 2019 cover 14 vaccine-preventable diseases. We characterize …

Background and objectives The goal of this literature review is to compare current studies
regarding the accuracy of different serum markers in differentiating viral from bacterial …

Community‐acquired pneumonia (CAP) is an important cause of death around the globe.
Up to 30% of patients admitted to hospital for CAP develop cardiovascular complications (ie …